Anaeropharma Science Overview
- Year Founded
-
2004
- Status
-
Out of Business
- Employees
-
20
- Latest Deal Type
-
Out of Business
Anaeropharma Science General Information
Description
Operator of a biopharmaceutical firm intended to provide safe therapies in oncology. The company's biopharmaceuticals consist of genetically enhanced bacteria that fight tumors and proliferate in the hypoxic core of solid tumors, where it secretes the enzyme cytosine deaminase turning a systemically administered pro-drug into a cytotoxic agent, enabling healthcare professionals to offer effective and safe therapy for cancers and for other hypoxic lesions related diseases.
Contact Information
Website
www.anaeropharma.co.jpCorporate Office
- Tokyo Park Tower 201, 1-103 Kanda Jinbocho
- Chiyoda-ku
- Tokyo, 101-0051
- Japan
Corporate Office
- Tokyo Park Tower 201, 1-103 Kanda Jinbocho
- Chiyoda-ku
- Tokyo, 101-0051
- Japan
Anaeropharma Science Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 30-Aug-2021 | Completed | Out of Business | |||
| 3. Later Stage VC | 05-Jul-2017 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series A) | 20-Feb-2012 | $28.4M | $36.9M | Completed | Generating Revenue | |
| 1. Seed Round | 25-Nov-2010 | $8.52M | $8.52M | Completed | Clinical Trials - General |
Anaeropharma Science Comparisons
Industry
Financing
Details
Anaeropharma Science Competitors (99)
One of Anaeropharma Science’s 99 competitors is Hansa Biopharma, a Corporation company based in Lund, Sweden.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Hansa Biopharma | Corporation | Lund, Sweden | ||||
| Dauntless Pharmaceuticals | Formerly VC-backed | San Diego, CA | ||||
| AB Science | Formerly Accelerator/Incubator backed | Paris, France | ||||
| Lion TCR | Venture Capital-Backed | Singapore, Singapore | ||||
| Alnylam Pharmaceuticals | Formerly VC-backed | Cambridge, MA |
Anaeropharma Science Patents
Anaeropharma Science Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2021038975-A1 | Bifidobacterium spp. expressing and secreting diabody-type bsab | Inactive | 28-Aug-2019 | ||
| WO-2018062225-A1 | Gene expression promotor for bifidobacterium genus bacteria | Inactive | 28-Sep-2016 | ||
| JP-WO2018062225-A1 | Promoter for gene expression of bifidobacterium bacteria | Inactive | 28-Sep-2016 | ||
| EP-3249043-B1 | A transformation plasmid | Active | 19-Jan-2015 | ||
| JP-6258526-B2 | Drug for ischemic disease | Inactive | 19-Jan-2015 | C12N15/746 |
Anaeropharma Science Signals
Anaeropharma Science FAQs
-
When was Anaeropharma Science founded?
Anaeropharma Science was founded in 2004.
-
Where is Anaeropharma Science headquartered?
Anaeropharma Science is headquartered in Tokyo, Japan.
-
What is the size of Anaeropharma Science?
Anaeropharma Science has 20 total employees.
-
What industry is Anaeropharma Science in?
Anaeropharma Science’s primary industry is Drug Discovery.
-
Is Anaeropharma Science a private or public company?
Anaeropharma Science is a Private company.
-
What is Anaeropharma Science’s current revenue?
The current revenue for Anaeropharma Science is .
-
How much funding has Anaeropharma Science raised over time?
Anaeropharma Science has raised $50.1M.
-
Who are Anaeropharma Science’s competitors?
Hansa Biopharma, Dauntless Pharmaceuticals, AB Science, Lion TCR, and Alnylam Pharmaceuticals are some of the 99 competitors of Anaeropharma Science.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process